Literature DB >> 769815

Cross reactivity of an alloantigen present on normal cells with the tumour-specific transplantation-type antigen of the acute myeloid leukaemia (SAL) of rats.

A B Wrathmell, C L Gauci, P Alexander.   

Abstract

Resistance can be induced in the syngeneic host (August rats) to a myelogeneous leukaemia of spontaneous origin, called SAL, by immunization with allogeneic cells derived form both normal and malignant tissues obtained from the Hooded rat strain. Serological experiments support the conclusion that the antigen involved-referred to as "Ho-SAL"-has the properties of a tumour specific transplantation-type antigen for SAL cells but is a widely expressed alloantigen found in both normal and malignant cells derived from Hooded rats. Antisera to it can be raised in Wistar rats.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 769815      PMCID: PMC2024939          DOI: 10.1038/bjc.1976.24

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  APPLICATIONS OF ISO-IMMUNE CYTOLYSIS USING RADIOLABELLED TARGET CELLS.

Authors:  A R SANDERSON
Journal:  Nature       Date:  1964-10-17       Impact factor: 49.962

2.  Passive immunity in mice against C57BL leukosis E.L. 4 by means of iso-immune serum.

Authors:  P A GORER; D B AMOS
Journal:  Cancer Res       Date:  1956-05       Impact factor: 12.701

3.  A preliminary investigation into the role of immunity in modifying the blood- borne spread of chemically induced rat sarcomas.

Authors:  J W Proctor; C M Rudenstam; P Alexander
Journal:  J Natl Cancer Inst       Date:  1974-12       Impact factor: 13.506

4.  Resistance of guinea pigs to leukemia following transfer of immunocompetent allogeneic lymphoid cells.

Authors:  D H Katz; L Ellman; W E Paul; I Green; B Benacerraf
Journal:  Cancer Res       Date:  1972-01       Impact factor: 12.701

5.  Mechanisms involved in the antileukemic effect of immunocompetent allogeneic lymphoid cell transfer.

Authors:  L Ellman; D H Katz; I Green; W E Paul; B Benacerraf
Journal:  Cancer Res       Date:  1972-01       Impact factor: 12.701

6.  Production of tumor-specific antibody in the xenogeneic host: use of blocking antibody.

Authors:  R S Weiner; J D Hubbard; M R Mardiney
Journal:  J Natl Cancer Inst       Date:  1972-10       Impact factor: 13.506

7.  Syngeneic immune serum specifically inhibits the motility of tumour cells.

Authors:  G A Currie; G C Sime
Journal:  Nat New Biol       Date:  1973-02-28

8.  The G-IX system. A cell surface allo-antigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome.

Authors:  E Stockert; L J Old; E A Boyse
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

9.  Immunological studies on mouse mammary tumors. VI. Further characterization of a mammary tumor antigen and its distribution in lymphatic cells of allogeneic mice.

Authors:  S Chang; R C Nowinski; K Nishioka; R F Irie
Journal:  Int J Cancer       Date:  1972-03-15       Impact factor: 7.396

10.  Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2.

Authors:  H Sato; E A Boyse; T Aoki; C Iritani; L J Old
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

View more
  1 in total

1.  Anti-tumour immunity by normal allogeneic blood transfusion in rat.

Authors:  T Oikawa; M Hosokawa; M Imamura; F Sendo; M Nakayama
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.